IL6 and type 2 diabetes mellitus: Elevated concentrations of markers and mediators of inflammation and acute-phase reactants, including C-reactive protein, interleukin (IL)-6, and plasminogen activator inhibitor-1, confirmed the epidemiologic associations between inflammation and obesity and type II diabetes [30,31,32,33,34].